Personalised medicine in carcinoma of unknown primary

The ESMO met with Prof. Karim Fizazi of the Department of Medicine, Institut Gustave Roussy, Villeiuif, France to discuss on how personalised medicine can improve the treatment of patients with carcinoma of unknown primary (CUP), molecular profiling and assays for tissue analysis, and how to demonstrate the effectiveness of molecular diagnostic tests. Read the short interview here.